Francheyska Silfa Mazara, MD - Medicare Pediatrics in Chelmsford, MA

Francheyska Silfa Mazara, MD is a medicare enrolled "Pediatrics" physician in Chelmsford, Massachusetts. Her current practice location is 3 Kirby Ln, Chelmsford, Massachusetts. You can reach out to her office (for appointments etc.) via phone at (617) 650-1685.

Francheyska Silfa Mazara is licensed to practice in Massachusetts (license number 231377) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1316137458.

Contact Information

Francheyska Silfa Mazara, MD
3 Kirby Ln,
Chelmsford, MA 01824-1276
(617) 650-1685
Not Available



Physician's Profile

Full NameFrancheyska Silfa Mazara
GenderFemale
SpecialityPediatrics
Location3 Kirby Ln, Chelmsford, Massachusetts
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1316137458
  • Provider Enumeration Date: 07/25/2007
  • Last Update Date: 01/10/2012
  Medicare PECOS Information:
  • PECOS PAC ID: 3870623804
  • Enrollment ID: I20100617000336

Medical Identifiers

Medical identifiers for Francheyska Silfa Mazara such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1316137458NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208000000XPediatrics 231377 (Massachusetts)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Francheyska Silfa Mazara allows following entities to bill medicare on her behalf.
Entity NameMassachusetts General Physicians Organization Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1801874573
PECOS PAC ID: 2466365820
Enrollment ID: O20031111000434

News Archive

OSI Pharmaceuticals' 2% Senior Subordinated Notes to remain convertible through July 6, 2010

OSI Pharmaceuticals, Inc. announced today that its 2% Convertible Senior Subordinated Notes due 2025 (the "notes") are convertible at the option of the holders and will remain convertible at least through July 6, 2010, as provided for in the Indenture governing the notes.

USA Today examines issues Supreme Court will decide in challenge to federal abortion ban

USA Today on Monday examined how Congress' "power to limit the reach" of Roe v. Wade - the 1973 U.S. Supreme Court case that effectively barred state abortion bans - by "restricting medical options for women" will be tested in the Department of Justice's appeal to the high court to uphold a federal law banning so-called "partial-birth" abortion.

Cancer Research UK opens olaparib-temozolomide combination Phase I trial in glioblastoma

Cancer Research UK's Drug Development Office has opened a trial of a new combination of drugs for the treatment of patients with brain cancer.

Younger children more likely to be diagnosed with ADHD than older peers within same school year

Younger primary school children are more likely to be diagnosed with attention deficit hyperactivity disorder (ADHD) than their older peers within the same school year, new research has shown.

Orchid Cellmark reports 21% increase in total revenues for fourth-quarter 2009

Orchid Cellmark Inc., a leading international provider of identity DNA testing services, today reported its financial results for the fourth quarter and full year of 2009.

Read more Medical News

› Verified 9 days ago

Entity NameNewton-wellesley Medical Group, Inc.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1538191218
PECOS PAC ID: 0244133494
Enrollment ID: O20040127001012

News Archive

OSI Pharmaceuticals' 2% Senior Subordinated Notes to remain convertible through July 6, 2010

OSI Pharmaceuticals, Inc. announced today that its 2% Convertible Senior Subordinated Notes due 2025 (the "notes") are convertible at the option of the holders and will remain convertible at least through July 6, 2010, as provided for in the Indenture governing the notes.

USA Today examines issues Supreme Court will decide in challenge to federal abortion ban

USA Today on Monday examined how Congress' "power to limit the reach" of Roe v. Wade - the 1973 U.S. Supreme Court case that effectively barred state abortion bans - by "restricting medical options for women" will be tested in the Department of Justice's appeal to the high court to uphold a federal law banning so-called "partial-birth" abortion.

Cancer Research UK opens olaparib-temozolomide combination Phase I trial in glioblastoma

Cancer Research UK's Drug Development Office has opened a trial of a new combination of drugs for the treatment of patients with brain cancer.

Younger children more likely to be diagnosed with ADHD than older peers within same school year

Younger primary school children are more likely to be diagnosed with attention deficit hyperactivity disorder (ADHD) than their older peers within the same school year, new research has shown.

Orchid Cellmark reports 21% increase in total revenues for fourth-quarter 2009

Orchid Cellmark Inc., a leading international provider of identity DNA testing services, today reported its financial results for the fourth quarter and full year of 2009.

Read more Medical News

› Verified 9 days ago

Entity NameThe General Hospital Corporation
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1023049236
PECOS PAC ID: 6507803806
Enrollment ID: O20080313000351

News Archive

OSI Pharmaceuticals' 2% Senior Subordinated Notes to remain convertible through July 6, 2010

OSI Pharmaceuticals, Inc. announced today that its 2% Convertible Senior Subordinated Notes due 2025 (the "notes") are convertible at the option of the holders and will remain convertible at least through July 6, 2010, as provided for in the Indenture governing the notes.

USA Today examines issues Supreme Court will decide in challenge to federal abortion ban

USA Today on Monday examined how Congress' "power to limit the reach" of Roe v. Wade - the 1973 U.S. Supreme Court case that effectively barred state abortion bans - by "restricting medical options for women" will be tested in the Department of Justice's appeal to the high court to uphold a federal law banning so-called "partial-birth" abortion.

Cancer Research UK opens olaparib-temozolomide combination Phase I trial in glioblastoma

Cancer Research UK's Drug Development Office has opened a trial of a new combination of drugs for the treatment of patients with brain cancer.

Younger children more likely to be diagnosed with ADHD than older peers within same school year

Younger primary school children are more likely to be diagnosed with attention deficit hyperactivity disorder (ADHD) than their older peers within the same school year, new research has shown.

Orchid Cellmark reports 21% increase in total revenues for fourth-quarter 2009

Orchid Cellmark Inc., a leading international provider of identity DNA testing services, today reported its financial results for the fourth quarter and full year of 2009.

Read more Medical News

› Verified 9 days ago

Entity NameBrigham And Women's Physicians Organization Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1033535497
PECOS PAC ID: 3870405988
Enrollment ID: O20150107001260

News Archive

OSI Pharmaceuticals' 2% Senior Subordinated Notes to remain convertible through July 6, 2010

OSI Pharmaceuticals, Inc. announced today that its 2% Convertible Senior Subordinated Notes due 2025 (the "notes") are convertible at the option of the holders and will remain convertible at least through July 6, 2010, as provided for in the Indenture governing the notes.

USA Today examines issues Supreme Court will decide in challenge to federal abortion ban

USA Today on Monday examined how Congress' "power to limit the reach" of Roe v. Wade - the 1973 U.S. Supreme Court case that effectively barred state abortion bans - by "restricting medical options for women" will be tested in the Department of Justice's appeal to the high court to uphold a federal law banning so-called "partial-birth" abortion.

Cancer Research UK opens olaparib-temozolomide combination Phase I trial in glioblastoma

Cancer Research UK's Drug Development Office has opened a trial of a new combination of drugs for the treatment of patients with brain cancer.

Younger children more likely to be diagnosed with ADHD than older peers within same school year

Younger primary school children are more likely to be diagnosed with attention deficit hyperactivity disorder (ADHD) than their older peers within the same school year, new research has shown.

Orchid Cellmark reports 21% increase in total revenues for fourth-quarter 2009

Orchid Cellmark Inc., a leading international provider of identity DNA testing services, today reported its financial results for the fourth quarter and full year of 2009.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Francheyska Silfa Mazara is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Francheyska Silfa Mazara, MD
3 Kirby Ln,
Chelmsford, MA 01824-1276

Ph: (617) 650-1685
Francheyska Silfa Mazara, MD
3 Kirby Ln,
Chelmsford, MA 01824-1276

Ph: (617) 650-1685

News Archive

OSI Pharmaceuticals' 2% Senior Subordinated Notes to remain convertible through July 6, 2010

OSI Pharmaceuticals, Inc. announced today that its 2% Convertible Senior Subordinated Notes due 2025 (the "notes") are convertible at the option of the holders and will remain convertible at least through July 6, 2010, as provided for in the Indenture governing the notes.

USA Today examines issues Supreme Court will decide in challenge to federal abortion ban

USA Today on Monday examined how Congress' "power to limit the reach" of Roe v. Wade - the 1973 U.S. Supreme Court case that effectively barred state abortion bans - by "restricting medical options for women" will be tested in the Department of Justice's appeal to the high court to uphold a federal law banning so-called "partial-birth" abortion.

Cancer Research UK opens olaparib-temozolomide combination Phase I trial in glioblastoma

Cancer Research UK's Drug Development Office has opened a trial of a new combination of drugs for the treatment of patients with brain cancer.

Younger children more likely to be diagnosed with ADHD than older peers within same school year

Younger primary school children are more likely to be diagnosed with attention deficit hyperactivity disorder (ADHD) than their older peers within the same school year, new research has shown.

Orchid Cellmark reports 21% increase in total revenues for fourth-quarter 2009

Orchid Cellmark Inc., a leading international provider of identity DNA testing services, today reported its financial results for the fourth quarter and full year of 2009.

Read more News

› Verified 9 days ago


Pediatrics Doctors in Chelmsford, MA

Chandra Ramanathan, M.D.
Pediatrics
Medicare: Not Enrolled in Medicare
Practice Location: 228 Billerica Rd, Chelmsford, MA 01824
Phone: 978-250-6000    
Dr. Mark Gordon Gilchrist, MD
Pediatrics
Medicare: Not Enrolled in Medicare
Practice Location: 4 Meeting House Rd, Chelmsford, MA 01824
Phone: 978-250-4081    Fax: 978-250-3956
Sheila L Morehouse, M.D.
Pediatrics
Medicare: Not Enrolled in Medicare
Practice Location: 7 Village Sq, Chelmsford, MA 01824
Phone: 978-256-4363    
Jennifer Marie Liano, MD
Pediatrics
Medicare: Medicare Enrolled
Practice Location: 228 Billerica Rd, Chelmsford, MA 01824
Phone: 978-250-6300    
Dr. Lorna Shaw Melo, M.D.
Pediatrics
Medicare: Not Enrolled in Medicare
Practice Location: 228 Billerica Rd, Pediatrics Dept, Chelmsford, MA 01824
Phone: 978-250-6300    
Beril Bayrak, MD
Pediatrics
Medicare: Medicare Enrolled
Practice Location: 7 Village Sq, Chelmsford, MA 01824
Phone: 978-256-4363    Fax: 978-256-1565

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.